Results for tag: "Denosumab"

Denosumab is a monoclonal antibody used to treat endocrine and metabolic disorders. It is used to treat osteoporosis, Paget's disease of bone, and bone metastases from solid tumors. It works by inhibiting the activity of osteoclasts, which are cells that break down bone. This helps to reduce bone loss and increase bone density. Denosumab is administered as an injection under the skin or into a vein. Denosumab is a relatively new drug, and is still in the process of being approved for use in various countries. It is currently approved in the United States, Canada, Europe, and other countries. It is also being studied for use in other endocrine and metabolic disorders. Some companies in the Denosumab market include Amgen, Novartis, and Merck. Show Less Read more